Business Description

Baxter International Inc., founded in 1931 and headquartered in Deerfield, Illinois, United States, is a global healthcare company focused on innovative medical devices, pharmaceuticals, and biotechnology products. It is best known for its advanced renal care systems, infusion pumps, and sterile solutions, which drive recurring revenue across hospitals and home care segments. Under the leadership of CEO José E. Almeida since 2016, Baxter maintains a top-five global ranking in its core markets. The company is actively investing in next-generation therapies and digital health initiatives while expanding its footprint in emerging markets.

Everything on Baxter International Inc.

Revenue (FY2025) $11.24B
YoY growth +5.7%
Operating margin -2.7%
Direction Expanding
Gross margin 30.1%
Net margin -8.0%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗
Baxter International acquires Gambro AB — Renal / dialysis · 2013 View full deal ↗ Baxter International acquires Hill-Rom Holdings, Inc. (Hillrom) — Connected care / medical technology · 2021 View full deal ↗ Baxter International acquires Claris Injectables Limited (Claris) — Generic injectable pharmaceuticals · 2017 View full deal ↗ Baxter International acquires Seprafilm Adhesion Barrier (product rights, from Sanofi) — Surgical / adhesion prevention · 2020 View full deal ↗ Baxter International acquires Synovis Life Technologies, Inc. — BioSurgery / soft-tissue repair · 2011 View full deal ↗ Baxter International acquires Caelyx and Doxil rights (ex-US, from a subsidiary of Johnson & Johnson) — Oncology pharmaceuticals · 2021 View full deal ↗ Baxter International acquires Cheetah Medical, Inc. (Cheetah) — Patient monitoring / hemodynamic monitoring · 2019 View full deal ↗ Baxter International acquires RECOTHROM and PREVELEAK products (from Mallinckrodt plc) — BioSurgery / hemostats and sealants · 2018 View full deal ↗ Baxter International acquires Transderm Scop (TDS) rights (from subsidiaries of GlaxoSmithKline) — Pharmaceuticals · 2021 View full deal ↗ Baxter International acquires PerClot Polysaccharide Hemostatic System (assets, from CryoLife, Inc.) — BioSurgery / hemostats · 2021 View full deal ↗ Baxter International acquires Baxa Corporation — Medical Products · 2011 View full deal ↗ Baxter International acquires SIGMA International General Medical Apparatus, LLC — Medical Products · 2012 View full deal ↗

Share Repurchase Program

Remaining (as of March 31, 2026)
$1.30 billion
Latest FY repurchased
$0 (no shares repurchased in 2025 or 2024)

Recent SEC Filings

2026-05-08 Leadership change (directors/officers) (+2 more) View filing ↗
2026-04-30 Reported quarterly results (+1 more) View filing ↗
2026-03-19 Regulation FD disclosure View filing ↗
2026-03-16 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-12 Reported quarterly results (+2 more) View filing ↗
2025-12-22 Other event View filing ↗
2025-12-04 Entered a material agreement (+3 more) View filing ↗
2025-11-25 Entered a material agreement View filing ↗
2025-11-19 Other event View filing ↗
2025-11-19 Other event View filing ↗
2025-11-12 Leadership change (directors/officers) View filing ↗
2025-10-30 Reported quarterly results View filing ↗

More Companies

See how VectorShift works for your firm

Request Demo